scispace - formally typeset
A

Annarosa Leri

Researcher at Brigham and Women's Hospital

Publications -  202
Citations -  40256

Annarosa Leri is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Stem cell & Myocyte. The author has an hindex of 88, co-authored 202 publications receiving 39365 citations. Previous affiliations of Annarosa Leri include Cardiovascular Institute of the South & University of Milan.

Papers
More filters
Journal ArticleDOI

The young mouse heart is composed of myocytes heterogeneous in age and function.

TL;DR: Physiologically and structurally, observations at the physiological and structural cellular level document that by necessity the heart has to constantly repopulate its myocyte compartment to replace senescent poorly contracting myocytes with younger more efficient cells, which regulates cardiac function.
Journal ArticleDOI

Myocyte cell death and ventricular remodeling

TL;DR: The documentation that mechanical forces in vitro, mimicking diastolic Laplace overloading in vivo, can transmit a death signal to myocytes suggests that programmed cell death may be triggered in the stressed myocardium independently from the etiology of the overload.
Journal ArticleDOI

Inhibition of Notch1-Dependent Cardiomyogenesis Leads to a Dilated Myopathy in the Neonatal Heart

TL;DR: Notch1 signaling is a critical determinant of CSC growth and differentiation; when this cascade of events is altered, cardiomyogenesis is impaired, physiological cardiac hypertrophy is prevented, and a life-threatening myopathy supervenes.
Journal ArticleDOI

Cardiac stem cell niches

TL;DR: The relevance of Notch1 signaling, gap-junction formation, HIF-1α and metabolic state in the regulation of stem cell growth and differentiation within the cardiac niches are discussed.
Journal ArticleDOI

Origin of Cardiomyocytes in the Adult Heart

TL;DR: The recognition of the origin of cardiomyocytes is of critical importance for the development of strategies capable of enhancing the growth response of the myocardium; in fact, cell therapy for the decompensated heart has to be based on the acquisition of this fundamental biological knowledge.